<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
     xmlns:dc="http://purl.org/dc/elements/1.1/"
     xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
     xmlns:admin="http://webns.net/mvcb/"
     xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
     xmlns:content="http://purl.org/rss/1.0/modules/content/"
     xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>JoriPress &#45; Gyan Solutions</title>
<link>https://joripress.com/rss/author/gyan-solutions</link>
<description>JoriPress &#45; Gyan Solutions</description>
<dc:language>en</dc:language>
<dc:rights>Copyright © 2025 JoriPress &#45; All Rights Reserved</dc:rights>

<item>
<title>Why Pharma Supply Chain Failures Are Structural, Not Temporary</title>
<link>https://joripress.com/pharma-supply-chain-failures-structural-not-temporary</link>
<guid>https://joripress.com/pharma-supply-chain-failures-structural-not-temporary</guid>
<description><![CDATA[ This article challenges the narrative that pharmaceutical supply chains will stabilize once disruptions pass. It examines why failures are structural rooted in regulatory design, biological variability, and global complexity not temporary problems waiting to be solved. ]]></description>
<enclosure url="https://joripress.com/uploads/images/202602/image_870x580_6984822c1ab0d.webp" length="22974" type="image/jpeg"/>
<pubDate>Thu, 05 Feb 2026 14:48:55 +0300</pubDate>
<dc:creator>Gyan Solutions</dc:creator>
<media:keywords>pharmaceutical supply chains</media:keywords>
</item>

</channel>
</rss>